Report from the Annual General Meeting of EQL Pharma AB (publ) on May 15th, 2017
At EQL Pharma's Annual General Meeting, which was held in Lund, May 15th, 2017, the following decisions were made:Adoption of the balance sheet and income statement, disposition regarding the Company’s results The annual general meeting resolved to adopt the balance sheet and income statement and the consolidated balance sheet and income statement for the financial year 2016. The annual general meeting also resolved that no dividends shall be paid for the financial year 2016. Discharge from liability for the Board of Directors and the Managing Director The annual general meeting